查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585728

輸血診斷市場：按產品類型、應用和最終用戶分類 - 全球預測 2025-2030

Blood Transfusion Diagnostics Market by Product Type (Instruments & Kits, Reagents), Application (Blood Grouping, Disease Screening), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，輸血診斷市場價值為35.1億美元，預計到2024年將達到38.6億美元，複合年成長率為9.79%，到2030年將達到67.6億美元。

輸血診斷市場包括用於篩檢、測試和分析的技術、設備和分析，以確保輸血的安全性和適用性。由於需要防止感染疾病的傳播、確保血液相容性以及維持輸血的整體安全性和有效性，該市場至關重要。應用範圍包括疾病篩檢、血型檢測、交叉配血、感染性物質檢測等，主要應用於醫院、血庫、診斷實驗室、研究所等。該市場的顯著成長是由於對安全輸血實踐的需求不斷增加、分子診斷的進步以及需要頻繁輸血的慢性疾病患病率的上升所推動的。核酸增幅檢查和次世代定序等新技術為更準確、更快速地檢測病原體提供了新的機會。該領域的公司可以透過投資基因檢測、用於預測診斷的人工智慧和即時檢測解決方案的創新研發來利用這些進步。然而，市場面臨嚴格的監管要求、先進診斷技術的高成本以及需要大量初始投資的挑戰。此外，低收入和中等收入國家的可近性低也是一個主要問題。為了緩解這些挑戰並抓住新的商機，企業將專注於開發具有成本效益且易於使用的診斷解決方案，探索與監管機構的夥伴關係和協作，並簡化核准。您也可以考慮擴大您在新興市場的影響力，那裡有大量開拓的基本客群。隨著對個人化醫療和數位健康工具整合的日益關注，這些創新努力可能會導致輸血診斷市場的變革性成長，而在醫療保健提供者和患者不斷變化的需求的推動下，公司將能夠更好地做出反應。

主要市場統計
基準年[2023] 35.1億美元
預測年份 [2024] 38.6億美元
預測年份 [2030] 67.6億美元
複合年成長率（%） 9.79%

市場動態：快速發展的輸血診斷市場的關鍵市場洞察

供需的動態交互作用正在改變輸血診斷市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 血友病和癌症等血液相關疾病的全球盛行率不斷上升
    • 政府支持的意識提升宣傳活動和對篩檢血液製品日益成長的需求
    • 世界各地交通事故、創傷和手術的增加
  • 市場限制因素
    • 缺乏基礎設施和熟練的專業人員
  • 市場機會
    • 技術先進的篩檢分析儀的可用性迅速增加
    • 整合實驗室和醫院核准的檢測設備
  • 市場挑戰
    • 營運成本高、執照監管政策嚴格

波特五力：駕馭輸血診斷市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解輸血診斷市場的外部影響

外部宏觀環境因素在塑造輸血診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解輸血診斷市場的競爭狀況

輸血診斷市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV定位矩陣輸血診斷市場供應商績效評估

FPNV定位矩陣是評估輸血診斷市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃輸血診斷市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對輸血診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 血友病和癌症等血液相關疾病的盛行率在全球範圍內不斷增加。
      • 隨著政府的支持和對經過測試的血液製品的需求，宣傳宣傳活動不斷擴大
      • 世界各地的交通事故、傷害和手術數量正在增加。
    • 抑制因素
      • 缺乏基礎設施和熟練的專業人員
    • 機會
      • 技術先進的篩檢分析儀的採用迅速增加
      • 在實驗室和醫院中整合已通過核准的儀器檢測
    • 任務
      • 營運成本高、核准監理政策嚴格
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章輸血診斷市場：依產品類型

  • 儀器和套件
  • 試劑

第7章輸血診斷市場：依應用分類

  • 血型
  • 疾病篩檢

第8章輸血診斷市場：依最終使用者分類

  • 診斷實驗室
  • 醫院
  • 血漿分餾公司

第9章北美和南美輸血診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太輸血診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲輸血診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • BAG Diagnostics GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fujirebio by HU Group
  • Grifols, SA
  • Immucor, Inc.
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • QuidelOrtho Corporation
  • Quotient Suisse SA
  • Thermo Fisher Scientific Inc.
  • Werfen, SA
Product Code: MRR-437D45958222

The Blood Transfusion Diagnostics Market was valued at USD 3.51 billion in 2023, expected to reach USD 3.86 billion in 2024, and is projected to grow at a CAGR of 9.79%, to USD 6.76 billion by 2030.

The blood transfusion diagnostics market encompasses the technologies, instruments, and assays used for the screening, testing, and analysis of blood to ensure its safety and compatibility for transfusion. This market is critical due to the necessity of preventing the transmission of infectious diseases, ensuring compatible blood matching, and maintaining overall transfusion safety and efficacy. Applications include disease screening, blood typing, cross-matching, and detecting infectious agents, primarily employed by hospitals, blood banks, diagnostic laboratories, and research institutions. The substantial growth in this market is driven by increasing demand for secure blood transfusion practices, advancements in molecular diagnostics, and the rising prevalence of chronic diseases that necessitate frequent transfusions. Emerging technologies such as nucleic acid amplification testing and next-generation sequencing are providing novel opportunities for more accurate and faster detection of pathogens. Companies in this space can capitalize on these advancements by investing in research and development to innovate within genetic testing, artificial intelligence for predictive diagnostics, and point-of-care testing solutions. However, the market is challenged by stringent regulatory requirements, high costs of advanced diagnostic technologies, and the necessity for substantial initial investments. Limited accessibility in low- and middle-income countries also poses a significant challenge. To mitigate these challenges and capture emerging opportunities, businesses should focus on developing cost-effective and user-friendly diagnostic solutions and explore partnerships or collaborations with regulatory bodies to streamline approvals. Market players may also consider expanding their presence in emerging markets, which provide a large untapped customer base. With the increasing focus on personalized medicine and the integration of digital health tools, these innovative efforts could lead to transformative growth within the blood transfusion diagnostics market, allowing businesses to better address the evolving needs of healthcare providers and patients.

KEY MARKET STATISTICS
Base Year [2023] USD 3.51 billion
Estimated Year [2024] USD 3.86 billion
Forecast Year [2030] USD 6.76 billion
CAGR (%) 9.79%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Transfusion Diagnostics Market

The Blood Transfusion Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of blood-related disorders such as hemophilia and cancer globally
    • Growing awareness campaigns with government support and demand for screened blood products
    • Rising cases of road accidents, trauma, and surgeries worldwide
  • Market Restraints
    • Dearth of infrastructure and skilled professional
  • Market Opportunities
    • Surge in availability of technologically advanced screening analyzers
    • Integration of approved instrument assays in laboratories and hospitals
  • Market Challenges
    • High operating cost and strict regulatory policies for approval

Porter's Five Forces: A Strategic Tool for Navigating the Blood Transfusion Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Transfusion Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Transfusion Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Transfusion Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Transfusion Diagnostics Market

A detailed market share analysis in the Blood Transfusion Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Transfusion Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Transfusion Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Transfusion Diagnostics Market

A strategic analysis of the Blood Transfusion Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Transfusion Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BAG Diagnostics GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Fujirebio by H.U. Group, Grifols, S.A., Immucor, Inc., Laboratory Corporation of America Holdings, Merck KGaA, QuidelOrtho Corporation, Quotient Suisse SA, Thermo Fisher Scientific Inc., and Werfen, S.A..

Market Segmentation & Coverage

This research report categorizes the Blood Transfusion Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Instruments & Kits and Reagents.
  • Based on Application, market is studied across Blood Grouping and Disease Screening.
  • Based on End-User, market is studied across Diagnostic Laboratories, Hospitals, and Plasma Fractionation Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of blood-related disorders such as hemophilia and cancer globally
      • 5.1.1.2. Growing awareness campaigns with government support and demand for screened blood products
      • 5.1.1.3. Rising cases of road accidents, trauma, and surgeries worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of infrastructure and skilled professional
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in availability of technologically advanced screening analyzers
      • 5.1.3.2. Integration of approved instrument assays in laboratories and hospitals
    • 5.1.4. Challenges
      • 5.1.4.1. High operating cost and strict regulatory policies for approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Transfusion Diagnostics Market, by Product Type

  • 6.1. Introduction
  • 6.2. Instruments & Kits
  • 6.3. Reagents

7. Blood Transfusion Diagnostics Market, by Application

  • 7.1. Introduction
  • 7.2. Blood Grouping
  • 7.3. Disease Screening

8. Blood Transfusion Diagnostics Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories
  • 8.3. Hospitals
  • 8.4. Plasma Fractionation Companies

9. Americas Blood Transfusion Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Blood Transfusion Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Blood Transfusion Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. BAG Diagnostics GmbH
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Danaher Corporation
  • 6. F. Hoffmann-La Roche AG
  • 7. Fujirebio by H.U. Group
  • 8. Grifols, S.A.
  • 9. Immucor, Inc.
  • 10. Laboratory Corporation of America Holdings
  • 11. Merck KGaA
  • 12. QuidelOrtho Corporation
  • 13. Quotient Suisse SA
  • 14. Thermo Fisher Scientific Inc.
  • 15. Werfen, S.A.

LIST OF FIGURES

  • FIGURE 1. BLOOD TRANSFUSION DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BLOOD TRANSFUSION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BLOOD TRANSFUSION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD TRANSFUSION DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD TRANSFUSION DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DISEASE SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PLASMA FRACTIONATION COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. BLOOD TRANSFUSION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. BLOOD TRANSFUSION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023